chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pain in joints starting 2 weeks after MMR vaccine in Junior High School. Went from running on the cross-country team to barely limping due to pain in knees.
got clots all over the body; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced got clots all over the body in Mar2021 and he passed away. Pfizer has not been reporting any effects of blood clot. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: got clots all over the body
twisted his knee on 23Feb and received a cortisone shot; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 17Feb2021 as 1st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Consumer stated her husband received the first dose of the Covid 19 vaccine on 17Feb2021 and he experienced twisted his knee on 23Feb2021. Therapeutic measures were taken as a result of twisted his knee which included a cortisone shot. His second dose was scheduled for 11Mar2021 and wanted to know if it was wrong that he received the cortisone. The outcome of event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
patient complains she felt tingling in ring and pinky finger and wrist of right hand after the vaccine. She has not seen her doctor or seek health care yet.
Temperature excursion - CDC recommend Re-vax. Pt revaccinated on 11/2/2021.
Feels miserable; Sore throat; Eyes real sore; Ache; Chills; A fever of 99°F; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels miserable), OROPHARYNGEAL PAIN (Sore throat), EYE PAIN (Eyes real sore), PAIN (Ache) and CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045j21a, 027a21a and 021b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced FEELING ABNORMAL (Feels miserable), OROPHARYNGEAL PAIN (Sore throat), EYE PAIN (Eyes real sore), PAIN (Ache), CHILLS (Chills) and PYREXIA (A fever of 99°F). At the time of the report, FEELING ABNORMAL (Feels miserable), OROPHARYNGEAL PAIN (Sore throat), EYE PAIN (Eyes real sore), PAIN (Ache), CHILLS (Chills) and PYREXIA (A fever of 99°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Dec-2021, Body temperature: 99 f (High) fever of 99°F.         Concomitant medication include cholesterol medication. Treatment information was not provided.
his eyes got swollen, watery, swelling almost shut; his eyes got swollen, watery, swelling almost shut; This is a spontaneous report from a contactable Pharmacist received via Pfizer-sponsored program . A 26-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 03Apr2021 (Age at vaccination 26 years old), as Dose 1, Single for covid-19 immunization. The patient's medical history included allergy to all types of pollen. The patient's concomitant medications were not reported. The reporter stated that the patient felt fine for the initial 30 minutes of observation. However, he informed the pharmacist that shortly after leaving his eyes got swollen, watery, swelling almost shut. He did not require the EpiPen he had at home. The patient said the following Monday went back to normal. The patient experienced his eyes got swollen, watery, swelling almost shut on 03Apr2021. Pharmacist had patient who received first dose of vaccine reported that 30 minutes after experiencing eyes swollen up to the point where almost swollen shut. The reporter said the following Monday went back to normal. The reporter wanted to know if swelling of the face was a common side effect. The reporter enquired if he patient should receive the 2nd dose of the covid vaccine. Outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient complained of feeling short of breath and having difficulty swallowing. She stated she just felt not right. This started approximately 1 hour after the booster vaccine was given.
hard lumps at filler sites above upper lip and under left eye - filler injected  7 months prior to vaccine; hard lumps at filler sites above upper lip and under left eye - filler injected  7 months prior to vaccine; This is a spontaneous report from a contactable nurse (patient). This 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # ekj5730), intramuscular at single dose in the right arm on 28Dec2020 13:00 for COVID-19 immunisation. Medical history included migraine, allergies to Codeine, Hydrocodone. Concomitant medications were not reported. On 29Dec2020 11:00, the patient experienced hard lumps at filler sites above upper lip and under left eye - filler injected  7 months prior to vaccine. The outcome of the events was not recovered. No treatment was performed. The patient was not pregnant at the time of vaccination. The vaccine was administered at Hospital Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination.
Idiopathic tachycardia- hospitalized and placed on medication. Daily headaches, Fibromyalgia (pain, insomnia, depression and anxiety), Hashimotos thyroiditis (2012, 2014).
expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant and Treatment medications was not specified
Expired vaccine inadvertently administered. No patient reaction. Repeated dose per CDC and Sanofi Pasteur.
This spontaneous report was received from a nurse referring to a 17 years old female patient. Information about pertinent medical history, concurrent conditions, and drug reactions/allergies was not provided. Concomitant therapy included sterile diluent. At unspecified time in 2018, the patient was vaccinated with, as first dose, M-M-R II (strength, dose detail, route, lot # and expiration date were not reported) and VARIVAX (strength, dose detail, route, lot # and expiration date were not reported) for prophylaxis. On 19-FEB-2019, the patient was inadvertently administered with PROQUAD (therapy type recombinant Human albumin (rHA); lot # R017630 with expiration date 18-DEC-2019; strength and dose detail were not reported) subcutaneously for prophylaxis. No adverse effects were reported. The causality of the events was not provided.
pt recvd vax & c/o feeling dizzy as walked to class, fell when got to desk, never completely blacked out; pt hyperventilated; c/o pain in rt arm, leg & hip; pt told mom acted as if was high-know what to say but couldn't; had spasms;
DIZZINESS; HEADACHE (PRESSURE ON HEAD); NAUSEA OFF AND ON; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, the subject experienced dizziness. On 15-MAR-2021, the subject experienced headache (pressure on head). On 15-MAR-2021, the subject experienced nausea off and on. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, headache (pressure on head), and nausea off and on. This report was non-serious.
Severe right-side abdominal pain (intermittent). Vomiting (started 10/8, early AM). White blood cells consistent with infection. I was 35 weeks pregnant and my baby was delivered via cesarean. 11/30/09 DC summary and hosp recs received for dates 10/8/09 to 10/12/09. DX: s/p c-section for breech presentation, s/p appendectomy. Presenting sx: 35wks gestation w/ severe RLQ pain, fever, abnormal labs. Assessment: pt was monitored for several hours, pain increased, pt taken to OR for appendectomy and C/S.
Shoulder injury related to vaccine administration.  As time has conditined, the cartilage has completely disolved, i.e. there is no longer cartilage remaining int he left shoulder.
Swelling, redness, pain. Diagnosed w/ cellulitis at urgent care and given antibiotic.
This spontaneous report as received from a pharmacist refers to an 84 year old female patient. Pertinent medical history and drug reactions were reported as none. On 16-DEC-2013, the patient was vaccinated with ZOSTAVAX (lot # J007858, expiration date 28-SEP-2013, single dose, subcutaneous). No concomitant therapy was reported. On December 2013, the patient had a permanent wave process on her hair performed at a beauty salon that was not effective. Patient called pharmacist. No lab diagnostics studies were performed. Patient had not received any treatment. The outcome of the event was unknown. Additional information has been requested.
Information has been received from a registered pharmacist concerning a female patient who on 18-FEB-2009 was vaccinated with ZOSTAVAX (Merck) subcutaneously. Concomitant therapy included " a statin". The patient had soreness at the injection site after ZOSTAVAX (Merck) was given. The registered pharmacist stated the patient then reported having "blotchy skin and not feeling well". The registered pharmacist further reported the patient's arm was still sore and she did not have full mobility of her arm. The registered pharmacist also stated there was "muscle pain in her arm as well as her arm pit". The patient had visited the registered pharmacist for medical attention. At the time of reporting the patient had not recovered from the adverse events. Additional information has been requested.
pt recv vax 26FEB97 & approx 5hr post vax exp vasodilation (feeling flushed) & sweating;these exp lasted about 20min then subsided;approx 9hr post vax pt exp a vasodilation;
Product storage error; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 21-Oct-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
On 2/29/00 or 3/1/00, the pt experienced trembling, was unresponsive and turned purple. The child was admitted to the hospital where a physician determined that he had had a seizure. No further information is available.
DTaP administered on 7/20/16. Beginning that night patient was fussy, waking up and crying frequently. For the next 5 wks, he woke almost hourly at night crying. After the vaccine he stopped "babbling and singing" vocalization and did not advance developmentally. SXs improved during the last week.
Patient states that on 3/23/2021 he developed TIA symptoms and went to ER for Increase Blood pressure of 224 systolic,   off balance.  He went to ER as this is where he was treated 3 yrs ago for stroke and this felt the same.  He states was seen by neurologist and MRI complete and no new event.  Currently on Plavix for prevention.  He was treated and blood pressure decreased.  they had him take extra dose of Plavix and added Metoprolol 50 mg.  A week later he had pain in right leg below knee and had Doppler done to R/O DVT and was Negative
Booster dose of Pfizer Covid-19 vaccine administered by the medical assistant without diluent 0.3ml concentrated dose. Patient observed for 30 minutes. No reaction. Patient monitor ongoing since event at follow-up visit 2 weeks later. No adverse reaction noted
Pfizer covid vaccine: positive for covid with fever; Pfizer covid vaccine: positive for covid with fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 78-year-old male patient received BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: EL9269, Expiration Date: 31May2021), on 04Mar2021 as dose  2, single (Lot number: EN6198, Expiration Date: 30Jun2021), on 11Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 02Aug2022 as dose 4 (booster), single (Lot number: FN2908) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (ongoing), notes: high blood pressure diagnosed about 5 years ago; "covid", start date: 06Nov2020 (unspecified if ongoing), notes: Covid (prior to vaccination) & then covid was not detected on 03Dec2020. No symptoms. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 08Feb2023, outcome "not recovered" and all described as "Pfizer covid vaccine: positive for covid with fever". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Feb2023) positive, notes: positive for covid; (Feb2023) positive, notes: tested for covid three days in a row; (Feb2023) positive, notes: tested positive for covid three days in a row; (Feb2023) positive, notes: tested positive for covid three days in a row. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: It was reported that dose 3 lot number - 320308D or 320308P, last letter might be a D (he was looking on vaccine record card).Started Paxlovid on day 1 of covid positive test, clarified started Paxlovid on 08Feb2023. Completed treatment (all 30 pills).He was prescribed Paxlovid when he had a fever, with his initial covid illness, he ran a fever for a day and a half and then cleared up.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300082945 Same patient, different product, different event;
hardly can get out of bed; strong body aches; headaches; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (hardly can get out of bed), MYALGIA (strong body aches), HEADACHE (headaches) and VOMITING (Vomiting) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, the patient experienced MOBILITY DECREASED (hardly can get out of bed), MYALGIA (strong body aches), HEADACHE (headaches) and VOMITING (Vomiting). At the time of the report, MOBILITY DECREASED (hardly can get out of bed), MYALGIA (strong body aches), HEADACHE (headaches) and VOMITING (Vomiting) outcome was unknown.            Concomitant medications were not reported.  Treatment medications were not reported.
Case number PHEH2015US024819 is a spontaneous report initially received from a health care professional on 23 Nov 2015. This report refers to a 59 year old female patient. Past vaccination history included an unknown vaccine was tolerated in the past. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) multi dose vial (MDV) intramuscularly at a dose of 0.5 ml on 23 Nov 2015 at 09:08 hours. It was reported that the vaccine administered was out of temperature range at 46.8 degree Fahrenheit for 24 hours. The case was reported as non serious. No adverse events were reported following the maladministration. Follow up information received from a healthcare professional on 21 Jan 2016: Added batch number, vaccination site and vaccination time.
Pt's mother called MD office stating that about 36 hrs after 2nd injection, the patient experienced swelling in her right arm that radiated down her arm into finger tips with middle of her back on right side. Her father is MD gave her 10 mg Prednisone with 800 mg Motrin. This was repeated by Dr next day. Manufacturer rep notified.
Left mid-thigh, left lower thigh, erythema on surface of thigh-over 9 cm x 12 cm.  No induration, moderate edema to entire left thigh.
Called patient to check on the reason he has not returned for his 2nd Moderna injection. Patient stated he has had issues moving his left arm and pain in arm since he has received his first shot. He called his PCP who advised him to go to ER for signs of stroke. Patient did not go to ER and has not been seen for his left arm pain and limited ROM. This nurse consulted with our medical director who stated that there has been cases of Neuropathy type issues in injection arm after COVID vaccine that he has came across in his practice. He suggested patient see PCP for assessment and possible treatment with steroid dose pack and anti-inflammatories.  This nurse instructed patient to contact PCP for further treatment and evaluation. Patient refuses second dose of Moderna at this time.
Information has been received from a physician concerning a baby who was vaccinated PO with a dose of ROTATEQ (no lot# provided). A day after vaccination, the patient became constipated, very "gassy" and the gas smelled like the rotavirus. The patient sought unspecified medical attention. The outcome was unknown. There was no product quality complaint. No further information is available.
A few days after the shot I noticed I had mild tinnitus. I have never had tinnitus before. It did not immediately occur to me that it might be connected to the vaccine; I learned about tinnitus as a symptom over a week later. The tinnitus has recurred regularly since receiving the vaccine on 4/20. Today is 5/7.
Insomnia, chills, fever, fatigue. Starting about 7 hours after the shot and lasting for about 30 hours.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On 17-JUL-2015, the patients were vaccinated with improperly stored doses of M-M-R II lot # J005706, expiration date 15-AUG-2015 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 51 degrees Fahrenheit for 15 hours. There were no previous excursions reported. Data logger: unspecified. Lot number J005706 is an invalid lot number for M-M-R II. This is one of several reports received from the same reporter. Additional information is not expected because there was no consent to contact healthcare worker.
Since shortly after first vaccine, patient has had much more frequent seizures than she has in the past. Seizure type is consistent with her known seizures, but previously had been only a couple over the course of many years. Starting after her vaccine they have been about weekly, and have continued to happen at this frequency.
She got her vaccine, nothing other than the usual arm pain.  The following day she had a slight peripheral vision problem on her left side, and that went away, occular migraines which she gets rarely but does get them.  Around 9:00 PM she got another occular migraine on the right side, and about the same time she lost the ability to speak, could not get words out, some words she could and diagnosed with expressive aphasia.  Thinking she was having a stroke, and she was with a friend and close to a hospital so they went to the hospital.  She was admitted until Monday night had EKG, echo, chest x-rays and a chemical work.  Diagnosis was probable TIA.    She was discharged on Monday, and was put on a baby aspirin, an and also Atorvastatin.  She now has a cardiologist and a neurologist for which she has no appointment for yet.  The cardiologist is ruling out A-fib with a heart monitor which she has not had applied yet.  She got home and took the week off and said that her brain and her body had been assulted, and took it easy and had no energy, all things that she expeced after that kind of a trauma.  She was very tired, just not feeling like herself.  She is better now, and awaiting her appointments, and is psychologically affected by this.  She is a very physical person, does very strenuous exercises and it's common for most people her age to play pickle ball and is actually nervous about all of that.    On 9/16/23 she had her flu shot, and had her latest COVID shot as well prior to the flu shot.  She did not have any reactions with those vaccines.    She saw her cardiologist yesterday and he said that he would not recommend any other vaccines.
Large red rash, pain, swelling at injectoin site. Patient returned to MD and has been taking BENADRYL.
Severe diffuse itching g developed about 4 days after the injection and has not resolved.  Present on bothe arms, legs, and trunk.  Results in rash and sores form itching.